Saquinavir mesylate oral dosage form
Номер патента: EP1646369A2
Опубликовано: 19-04-2006
Автор(ы): Antonio A. Albano, LIN Zhang, Martin Howard Infeld, Navnit-Hargovindas Shah, Wantanee Phuapradit
Принадлежит: F Hoffmann La Roche AG
Опубликовано: 19-04-2006
Автор(ы): Antonio A. Albano, LIN Zhang, Martin Howard Infeld, Navnit-Hargovindas Shah, Wantanee Phuapradit
Принадлежит: F Hoffmann La Roche AG
Реферат: A solid unit oral pharmaceutical dosage form of saquinavir mesylate is provided comprising micronized saquinavir mesylate in an amount of from 250 mg to 800 mg calculated as free base, and a pharmaceutically acceptable binder, disintegrant, and water soluble carrier. A solid unit dosage form of saquinavir mesylate is provided comprising from 60% to 80% micronized saquinavir mesylate based on the mesylate salt, 4% to 8% water soluble binder, a disintegrant and a carrier, wherein each percentage is of the kernel weight.
Saquinavir mesylate oral dosage form
Номер патента: US20050009811A1. Автор: LIN Zhang,Navnit Shah,Wantanee Phuapradit,Antonio Albano,Martin Infeld. Владелец: Individual. Дата публикации: 2005-01-13.